NCT05905653View on ClinicalTrials.gov

Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 25, 2023

Primary Completion Date

June 21, 2023

Study Completion Date

June 21, 2023

Conditions
Healthy Adult Males Volunteers
Interventions
DRUG

STN1012600 ophthalmic solution 0.002%

1 drop STN1012600 ophthalmic solution 0.002% once daily for 7 days

Trial Locations (1)

Unknown

Medical Corporation Heishinkai OPHAC Hospital, Osaka

All Listed Sponsors
lead

Santen Pharmaceutical Co., Ltd.

INDUSTRY

NCT05905653 - Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers | Biotech Hunter | Biotech Hunter